Please ensure Javascript is enabled for purposes of website accessibility

Here's Why Rite Aid Corporation Staged a 14% Comeback Last Month

By Cory Renauer - Mar 4, 2017 at 8:24AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors appeared more confident that a Walgreens acquisition of Rite Aid will cross antitrust hurdles.

What happened

After a rough start to the year, shares of retail pharmacy chain Rite Aid Corporation (RAD 2.75%) rose 13.9% in February, according to data from S&P Global Market Intelligence. Rumors that the Federal Trade Commission (FTC) will allow Walgreens Boots Alliance (WBA 1.36%) to complete its stalled acquisition lifted the stock.

So what 

The acquisition has been in the works for over a year now, giving investors plenty of reasons to be nervous. Walgreens is expected to raise the number of stores it will sell to Fred's (FRED) pharmacy chain from 865 to as high as 1,200, according to the New York Post.

Pills stacked to form an upward sloping chart with a dollar sign at the end.

Image source: Getty Images.

At the end of January, Walgreens and Rite Aid amended their previous agreement to reflect the number of stores to be divested in order to please regulators. The new deal lowers the purchase price from $9.00 per share of Rite Aid to $7.00 if it needs to cut 1,000 stores or $6.50 if the FTC insists on a 1,200-store reduction.

Now what

When industries consolidate, companies are generally left with two choices: get big enough to compete or get crushed. CVS Health's expansion into Target stores across the nation puts a bit more pressure on Walgreens to complete the deal. It also makes companies like Fred's hungry for any scraps that fall from the table.

At recent prices, Rite Aid stock is still about 18% below the lower end of the amended deal price of $6.50 per share. There are no guarantees the deal will go through, but it seems more likely than not. Although big mergers within the healthcare sector seemed like a non-starter in the previous administration, I'd be shocked if the FTC doesn't soften its stance while Trump is in the White House.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Rite Aid Corporation Stock Quote
Rite Aid Corporation
RAD
$6.92 (2.75%) $0.18
Walgreens Boots Alliance, Inc. Stock Quote
Walgreens Boots Alliance, Inc.
WBA
$38.41 (1.36%) $0.52
Fred's, Inc. Stock Quote
Fred's, Inc.
FRED

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
311%
 
S&P 500 Returns
110%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/01/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.